Señales en vivo de ALPHE.PA | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 jun 2023 @ 11:35):

Pherecydes Pharma SA develops antibacterial treatments based on the use of bacteriophage viruses or phages. It develops a portfolio of therapeutics, such as anti-Staphylococcus aureusphages for the treatment of bone/joint and diabetic foot ulcer infections; anti-Pseudomonas aeruginosa phages for the treatment of complicated urinary tract infections; and anti-Escherichia coli phages for the treatment of respiratory tract infections...

Stats
Volumen de hoy	3 154.00
Volumen promedio	10 506.00
Capitalización de mercado	15.83M
EPS	€0 ( 2023-03-07 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-2.67
ATR14	€0.103 (5.23%)

Volumen Correlación

Largo: -0.09 (neutral)

Corto: -0.21 (neutral)

Signal:(46.402) Neutral

Pherecydes Pharma Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pherecydes Pharma Correlación - Moneda/Commodity

-0.03
( neutral )

-0.61
( weak negative )

0.00
( neutral )

0.07
( neutral )

0.76
( moderate )

Pherecydes Pharma Finanzas

Annual	2022
Ingresos:	€3.16M
Beneficio Bruto:	€-93 178.00 (-2.95 %)
EPS:	€-0.750

FY	2022
Ingresos:	€3.16M
Beneficio Bruto:	€-93 178.00 (-2.95 %)
EPS:	€-0.750

FY	2021
Ingresos:	€2.14M
Beneficio Bruto:	€659 036 (30.76 %)
EPS:	€-0.564

FY	2019
Ingresos:	€2.26M
Beneficio Bruto:	€0.00 (0.00 %)
EPS:	€-0.216

Financial Reports:

No articles found.

Pherecydes Pharma